Riskpilot← Back to searchSign inGet full accessDoktor Jon AB
ABActiveOrg 5592780885Övningsstigen 11General medical practice activities · NACE 8621Est. 20201 employees
Revenue 2025
SEK -4
-100% vs 2024
EBITDA margin
5240250.0%
-165% vs 2024
Equity ratio
93.4%
Financial strength
Net profit 2025
SEK -148K
-180% vs 2024
| Revenue | SEK -4 | -100% |
| EBITDA | SEK -210K | -165% |
| Net profit | SEK -148K | -180% |
| Total assets | SEK 145K | -64% |
| Equity | SEK 136K | -52% |
| Employees | 1 | — |
Legal name
Doktor Jon AB
Org number
5592780885
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 oktober 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva, direkt eller genom dotterbolag rekrytering och uthyrning av personal inom vård och omsorg samt därmed förenlig verksamhet. Äga och förvalta fastigheter och värdepapper samt därmed förenlig verksamhet. Därtill ska bolaget bedriva backläkar-, helikopter- och flygsjukvård.
Address
Övningsstigen 11
Email
joncachrimanidis@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 264 | 306 | 386 | 522 | −0 |
| Staff expenses | — | −55 | −5 | −25 | −15 |
| EBITDA | 177 | 149 | 276 | 324 | −210 |
| Depreciation & amort. | −7 | −13 | −15 | −15 | −15 |
| EBIT | 170 | 135 | 261 | 309 | −225 |
| Net financials | — | −0 | −0 | 2 | −0 |
| Profit before tax | 170 | 135 | 261 | 233 | −148 |
| Tax | −37 | −29 | −52 | −48 | — |
| Net profit | 133 | 107 | 209 | 185 | −148 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 224 | 216 | 363 | 401 | 145 |
| Equity | 158 | 135 | 273 | 284 | 136 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 66 | 81 | 89 | 40 | 10 |
| Total debt | 66 | 81 | 89 | 40 | 10 |
EBITDA margin
-20961000.0%
This company
15.8%
Market median
-132664657% vs market
20212025
Equity ratio
93.4%
This company
38.2%
Market median
+145% vs market
20212025
Return on equity
-109.1%
This company
18.4%
Market median
-693% vs market
20212025
Net profit margin
-14791500.0%
This company
8.1%
Market median
-182611211% vs market
20212025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JA Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doktor Jon AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Aristotelis Cachrimanidis | Chief Executive Officer | 0 companies |
| Frida Magdalena Lindmark | Deputy Board Member | 0 companies |
| Efrem Cachrimanidis | Deputy Board Member | 0 companies |